Biotech Veteran Bob Langer Teams Up with Son in New Venture Firm T.Rx Capital.

Bob Langer, co-founder of Moderna, has teamed up with his son Michael and other healthcare-industry veterans to form T.Rx Capital, a new venture firm that has raised $77.5 million to invest in life sciences and healthcare-technology startups. T.Rx secured an anchor investor and held a final closing on the fund in July, short of its $125 million target.

Bob Langer, the co-founder of Moderna and a pioneer in biotechnology, has joined forces with his son Michael and other healthcare-industry veterans to establish T.Rx Capital, a new venture firm focused on life sciences and healthcare-technology startups. The fund, based in Boston, has successfully raised $77.5 million to date, with an anchor investor contributing to the effort Biotech Veteran Bob Langer, Son, Team Up in Venture Firm T.Rx Capital^[2].

T.Rx Capital held its final closing in July, falling short of its initial $125 million target. Despite this, the firm has secured significant backing, including a substantial investment from a large wealth-management firm Biotech Veteran Bob Langer, Son, Team Up in Venture Firm T.Rx Capital^[2]. The fund is poised to support innovative startups in the life sciences and healthcare technology sectors, with a focus on cutting-edge technologies such as antibody therapeutics, cell therapies, gene therapies, and diagnostics.

The venture firm's formation comes at a time when the biotechnology and healthcare sectors are experiencing rapid growth and innovation. With Langer's extensive experience and network, T.Rx Capital aims to identify and nurture promising startups that have the potential to revolutionize these industries.